This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Redondo, M. Articles by Garrido, F. Search for Related Content PubMed PubMed Citation Articles by Redondo, M. Articles by Garrido, F.

Altered HLA Class I Expression in Non-Small Cell Lung Cancer Is Independent of c-myc Activation¹

Servicio de Analisis Clinicos e Immunologia [M. R., F. R-C., T. C., M. P-A., M. R. O., F. G.] and Servicio de Anatomia Patológica [A. C.], Hospital Virgen de las Nieves, Universidad de Granada, Granada 18014, Spain

We studied the expression of major histocompatibility complex class I antigens in 59 bronchogenic carcinomas, as well as in pneumocytes and epithelial respiratory cells distant from the tumor. We observed in all cases that normal lung tissue expressed major histocompatibility complex class I antigens, while this expression was completely lost in 16 tumors (27%). The defect in HLA gene expression affected both heavy chain and ß₂-microglobulin, as demonstrated by the null reactivity with the monoclonal antibodies GRH1, W6/32, and HC10. Selective underexpression was detected in 1 tumor for HLA-A locus antigens and in 3 tumors for HLA-B locus antigens.

Southern blot analyses of major histocompatibility complex class I genes were performed in 20 tumor tissue specimens and 6 cell lines. No class I gene rearrangements were detected using HLA coding and locus specific noncoding probes.

We also used the Southern blot method to investigate the possible relationship between c-myc amplification and HLA class I antigens in non-small cell lung cancers and detected no apparent amplification in 20 tumor tissue specimens (5 negative for HLA class I antigens) and 6 cell lines (3 with decreased expression).

Northern blot analysis revealed no relationship between c-myc mRNA levels and specific mRNA for HLA-A and HLA-B antigens in cell lines with imbalanced HLA-A or HLA-B expression.

¹ This work was partially supported by the Fondo de Investigaciones Sanitarias de la Seguridad Social and the Plan Andaluz de Investigación, Universidad de Granada, Spain.

² To whom requests for reprints should be addressed.

Received 10/29/90. Accepted 2/21/91.